References
- CDC. Diminishing racial disparities in early-onset neonatal group B streptococcal disease–United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2004;53:502–505.
- Dahl MS, Tessin I, Trollfors B. Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis. Int J Infect Dis. 2003;7:113–119.
- Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15–20.
- Davies HD, Adair CE, Schuchat A, et al. Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ. 2001;164:479–485.
- Andersen J, Christensen R, Hertel J. Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr. 2004;93:1334–1349.
- Johnson JR, Colombo DF, Gardner D, et al. Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus. Am J Obstet Gynecol. 2001;185:850–853.
- Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299:2056–2065.
- Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 1993;328:1807–1811.
- Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis. 2009;49:85–92.
- Davies HD, Raj S, Adair C, et al. Group AGS. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J. 2001;20:879–884.
- Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia, PA: WB Saunders, 1995. pp 980–1054.
- Castrodale L, Gessner B, Hammitt L, et al. Invasive early-onset neonatal group B streptococcal cases–Alaska, 2000-2004. Matern Child Health J. 2007;11:91–95.
- Kristensen B, Schonheyder HC. A 13-year survey of bacteraemia due to beta-haemolytic streptococci in a Danish county. J Med Microbiol. 1995;43:63–67.
- Moses LM, Heath PT, Wilkinson AR, et al. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed. 1998;79:F148–F149.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
- May M, Daley AJ, Donath S, Isaacs D, Australasian Study Group for Neonatal I. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Arch Dis Child Fetal Neonatal Ed. 2005;90:F324–F327.
- Lyytikainen O, Nuorti JP, Halmesmaki E, et al. Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis. 2003;9:469–473.
- Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study–1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis. 2000;182:168–173.
- Lessa FC, Mu Y, Davies J, et al. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis. 2010;51:925–928.
- Laupland KB, Schonheyder HC, Kennedy KJ, et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Res Notes. 2009;2:146.
- Laupland KB, Lyytikainen O, Sogaard M, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19:465–471.
- Guest C, Halliday L, Kee C, et al. Chief Health Officer's Report. In: Division PH, editor. Canberra: Australia Capital Territory, 2010.
- Association CD. Canada at the tipping point. Canadian Diabetes Association, 2010.
- Denmark S. Out-patient treatments by region, diagnosis, age and sex. 2010. Available online at: http://www.statbank.dk/AMB01. Accessed
- Marrett L, Chappell H, De P, et al. Canadian Cancer Statistics. In: Society CC, editor. Toronto: Public Health Agency of Canada, 2010.
- NORDCAN. Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries [database on the Internet]. Association of the Nordic Cancer Registries. Danish Cancer Society, 2015. Available online at: http://www-dep.iarc.fr/NORDCAN/DK/frame.asp. Accessed 20 August 2015.
- AIHW. Cancer In Australia an overview 2010. Canberra: Australian Institute of Health and Welfare, 2010. Available onlie at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442472684. Accessed 20 Augsut 2015.
- Canada HaSFo Statistics. Heart & Stroke Foundation; 2010. Available online at: http://www.heartandstroke.ab.ca/site/c.lqIRL1PJJtH/b.3650897/k.35F8/Statistics.htm#references. Accessed 20 august 2015.
- AIHW. Cardiovascular Disease Australian facts 2011. Canberra: Australian Institute of Health and Welfare, 2011. Available online at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737418530. Accessed 10 August 2015.
- Denamiel G, Llorente P, Carabella M, et al. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina. J Vet Med B Infect Dis Vet Public Health. 2005;52:125–128.
- Lambertsen L, Ekelund K, Skovsted IC, et al. Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004. Eur J Clin Microbiol Infect Dis. 2010;29:1071–1077.
- Skogberg K, Lyytikainen O, Ruutu P, et al. Increase in bloodstream infections in Finland, 1995–2002. Epidemiol Infect. 2008;136:108–114.
- Richards VP, Lang P, Bitar PD, et al. Comparative genomics and the role of lateral gene transfer in the evolution of bovine adapted Streptococcus agalactiae. Infect Genet Evol. 2011;11:1263–1275.
- Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014;27:647–664.
- Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect. 2005;11:569–576.
- Kristensen B, Schønheyder HC. A 13-year survey of bacteraemia due to beta-haemolytic streptococci in a Danish county. J Med Microbiol. 1995;43:63–67.
- Schugk J, Harjola VP, Sivonen A, et al. A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. Scand J Infect Dis. 1997;29:233–238.
- Thomsen RW, Riis AH, Kjeldsen S, Schonheyder HC. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect. 2011;63:8–16.
- Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl 1):S27–S36.
- Centers for Disease Control and Prevention. Increasing prevalence of diagnosed diabetes–United States and Puerto Rico, 1995–2010. MMWR Morb Mortal Wkly Rep. 2012;61:918–921.